摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[Ru2(p-cymene)2(μ-9,10-dioxido-1,4-anthraquinonato)Cl2] | 201941-87-9

中文名称
——
中文别名
——
英文名称
[Ru2(p-cymene)2(μ-9,10-dioxido-1,4-anthraquinonato)Cl2]
英文别名
[Ru2(p-cymene)2(μ-9,10-dioxido-1,4-anthraquinonato)Cl2];((η6-p-cymene)Ru)2(1,4-dihydroxyanthraquinone)Cl2;[Ru2(p-cymene)2(1,4-dihydroxyanthraquinone)Cl2];[η6-(p-cymene)2Ru2(1,4-dihydroxyanthraquinonato)(Cl)2],;[Ru2(p-cymene)2(μ-doaq)Cl2];((η6-p-cym)Ru)2(dhaq)Cl2;[Ru2(p-cymene)2(dhaq)Cl2]
[Ru2(p-cymene)2(μ-9,10-dioxido-1,4-anthraquinonato)Cl2]化学式
CAS
201941-87-9
化学式
C34H34Cl2O4Ru2
mdl
——
分子量
779.688
InChiKey
JHKUUZMYSJXQRD-UHFFFAOYSA-J
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    描述:
    2,4,6-三(4-吡啶)1,3,5-三嗪[Ru2(p-cymene)2(μ-9,10-dioxido-1,4-anthraquinonato)Cl2]silver trifluoromethanesulfonate 以 methanol 为溶剂, 以76%的产率得到[Ru2(p-cymene)2Cl2(9,10-dioxo-9,10-dihydroanthracene-1,4-diolato)]3(2,4,6-tris(4-pyridyl)-1,3,5-triazine) trifluoromethanesulfona
    参考文献:
    名称:
    六核芳烃钌棱镜中芳香分子的永久包封或主客体行为
    摘要:
    通式为 [Ru6(p-cymene)6(tpt)2(OO∩OO)3]6+ {tpt = 2,4,6-tris(4-pyridyl)-1,3,5 的阳离子芳烃钌金属棱镜-三嗪;OO∩OO = 9,10-dioxo-9,10-dihydroanthracene-1,4-diolato [1]6+, 6,11-dioxo-6,11-dihydronaphthacene-5,12-diolato [2]6+}已经从相应的双核芳烃钌配合物 [Ru2(p-cymene)2(OO∩OO)Cl2] 与 tpt 和三氟甲磺酸银反应获得。在这些金属棱柱的合成过程中存在的芳香分子(菲、芘、苯并苯、晕苯)被永久封装以提供 carceplex 系统。所有空笼 ([1]6+ 和 [2]6+) 和 carceplex 系统 ([guest⊂1]6+ 和 [guest⊂2]6+) 均以高产率分离为三氟甲磺酸盐,并通过 NMR、UV
    DOI:
    10.1002/ejic.201000191
  • 作为产物:
    描述:
    [ruthenium(II)(η6-1-methyl-4-isopropyl-benzene)(chloride)(μ-chloride)]21,4-二羟基蒽醌甲醇 为溶剂, 生成 [Ru2(p-cymene)2(μ-9,10-dioxido-1,4-anthraquinonato)Cl2]
    参考文献:
    名称:
    两个双核Ru(ii)复合物的链间DNA共价结合。架桥配体的额外环对DNA相互作用和细胞毒活性的影响†
    摘要:
    在这项工作中,我们报告了实验和计算证据,证明可将游离醌奎尼沙林(Q)和萘酚(N)插入DNA碱基对中,以及它们的对-Cymene二钌(II)复合物的链间共价结合( Cl 2 Ru 2 X,其中X = N,Q桥接配体。N络合物的嵌入程度大于Q的嵌入程度,这与相同C X / C DNA的较高相对轮廓长度和较高的解链温度高度吻合N和Q分别与配体和最接近的碱基对(3.34Å和3.19Å)之间的平均比和计算的平均堆积距离有关。然而,Q / DNA的表观结合常数比N / DNA的表观结合常数高两个数量级,这表明X / DNA配合物的热稳定性与插层程度有关,而不是与结合常数的大小有关。Cl 2 Ru 2 X络合物进行水合,形成水族衍生物[(H 2 O)2 Ru 2 X] 2+。这些可以进一步通过Ru中心和连续鸟嘌呤的两个N7位点通过链间交联与DNA共价结合,得到(DNA 1,2)Ru 2X络合物,其作用机
    DOI:
    10.1039/c6dt04888a
点击查看最新优质反应信息

文献信息

  • In- and Out-of-Cavity Interactions by Modulating the Size of Ruthenium Metallarectangles
    作者:Nicolas P. E. Barry、Julien Furrer、Bruno Therrien
    DOI:10.1002/hlca.200900422
    日期:——
    Cationic (arene)ruthenium‐based tetranuclear complexes of the general formula [Ru4(η6‐p‐cymene)4(μ‐N∩N)2(μ‐OO∩OO)2]4+ were obtained from the dinuclear (arene)ruthenium complexes [Ru2(η6‐p‐cymene)2(μ‐OO∩OO)2Cl2] (p‐cymene=1‐methyl‐4‐(1‐methylethyl)benzene, OO∩OO=5,8‐dihydroxy‐1,4‐naphthoquinonato(2−), 9,10‐dihydroxy‐1,4‐anthraquinonato(2−), or 6,11‐dihydroxynaphthacene‐5,12‐dionato(2−)) by reaction
    阳离子(芳烃)通式[Ru中的基于的四核配合物4(η 6 -p -cymene)4(μ-N ∩ Ñ)2(μ-OO∩OO)2 ] 4+,从双核获得的(芳烃络合物的[Ru 2(η 6 - p -cymene)2(μ-OO∩OO)22 ](p -cymene = 1-甲基-4-(1-甲基乙基)苯,OO∩OO= 5,8-二羟基-1,4-萘醌(2-),9,10-二羟基-1,4-蒽醌(2-)或6,11-二羟基并五(12-dionato)(2-))通过与吡嗪或联吡啶接头(反应ñ ∩ ñ =吡嗪4,4'-联吡啶,4,4' - [(1- ë) -乙烯-1,2-二基]双[吡啶])中的存在下三氟甲磺酸盐(CF 3 SO 3 Ag)(方案)。以CF 3 SO盐的形式高收率分离出所有4 – 12配合物,并通过NMR和IR光谱进行表征。掺入4,4'-联吡啶和(4,4'-[(1 E乙烯-1,2-二基]双[
  • Self-Assembly of Novel Thiophene-Based BODIPY Ru<sup>II</sup> Rectangles: Potential Antiproliferative Agents Selective Against Cancer Cells
    作者:Gajendra Gupta、Abhishek Das、Sourav Panja、Ji Yeon Ryu、Junseong Lee、Nripendranath Mandal、Chang Yeon Lee
    DOI:10.1002/chem.201704368
    日期:2017.12.6
    Novel Ru (2+2) rectangles were designed and synthesized by self‐assembly of a new thiophene‐functionalized dipyridyl BODIPY ligand, BDPS, and ruthenium(II) precursors. The complexes exhibited dose‐dependent antiproliferative activities against cancer cells, in which some compounds selectively kill cancer cells. The net fluorescence due to BODIPY allowed us to visualize their location inside cancer
    通过新型噻吩官能化的二吡啶基BODIPY配体BDPS和(II)前体的自组装,设计并合成了新型Ru(2 + 2)矩形。该复合物对癌细胞具有剂量依赖性的抗增殖活性,其中某些化合物选择性杀死癌细胞。BODIPY产生的净荧光使我们能够看到它们在癌细胞中的位置。此外,属矩形显示出与生物分子结合的强烈倾向。
  • Anticancer activity of tetracationic arene ruthenium metalla-cycles
    作者:Nicolas P. E. Barry、Fabio Edafe、Bruno Therrien
    DOI:10.1039/c1dt10489f
    日期:——
    A series of cationic metalla-cycles of the general formulae [(η6-p-cym)4Ru4(OO∩OO)2(N∩N)2]4+ and [(η6-p-cym)4Ru4(NO∩NO)2(N∩N)2]4+ has been prepared from the dinuclear arene ruthenium precursors [(η6-p-cym)2Ru2(OO∩OO)2Cl2] (OO∩OO = oxalato, 1,4-benzoquinonato-2,5-diolato, 1,4-naphtoquinonato-5,8-diolato, 9,10-anthraquinonato-1,4-diolato, 5,12-tetraquinonato-6,11-diolato) and [(η6-p-cym)2Ru2(NO∩NO)2Cl2] (NO∩NO = oxamido, oxonico) by reaction with two different bidentate linkers (N∩N = 1,2-bis(4-pyridyl)ethylene, 1,2-bis(4-pyridyl)ethane) in the presence of silver triflate. All complexes were isolated as triflate salts and characterised by NMR, infrared, UV-visible, mass spectrometry and by elemental analysis. The cytotoxicities of the tetranuclear ruthenium complexes have been established using ovarian A2780 and A2780cisR cancer cell lines. All complexes exhibit moderate to excellent activity on both the cisplatin resistant and cisplatin sensitive cells, thus suggesting a mode of action different from cisplatin.
    一系列通式为[(η6-p- cym)4Ru4(OO∩OO)2(N∩N)2]4+ 和[(η6-p- cym)4Ru4(NO∩NO)2(N∩N)2]4+ 的阳离子属环已从二核前体中制备出来。cym)4Ru4(NO∩NO)2(N∩N)2]4+和[(η6-p-cym)4Ru4(OO∩OO)2(N∩N)2]4+是由双核前体[(η6-p-cym)2Ru2(OO∩OO)2Cl2](OO∩OO = 草酸、1,4-苯醌-2,5-二醇、1、4-醌-5,8-二醇、9,10-蒽醌-1,4-二醇、5,12-四喹啉-6,11-二醇)和[(η6-p-ym)2Ru2(NO∩NO)2Cl2](NO∩NO = 氧基、N∩N=1,2-双(4-吡啶基)乙烯1,2-双(4-吡啶基)乙烷)与两种不同的双齿连接体在三氟化银存在下反应生成。所有络合物都以三酸盐的形式分离出来,并通过核磁共振、红外、紫外-可见、质谱和元素分析进行了表征。利用卵巢 A2780 和 A2780cisR 癌细胞系确定了四核配合物的细胞毒性。所有复合物对顺铂耐药细胞和顺铂敏感细胞都表现出中等到卓越的活性,从而表明其作用模式与顺铂不同。
  • Encapsulation of Photosensitizers in Hexa- and Octanuclear Organometallic Cages: Synthesis and Characterization of Carceplex and Host–Guest Systems in Solution
    作者:Julien Freudenreich、Claudio Dalvit、Georg Süss-Fink、Bruno Therrien
    DOI:10.1021/om400237c
    日期:2013.5.24
    . These cationic hexa- and octanuclear cages have been isolated and characterized as their triflate salts. Addition of coronene during the synthesis of the large hexanuclear assemblies leads to the direct encapsulation of coronene in the cavity of the trigonal-prismatic complexes. Photosensitizers such as porphin, phthalocyanine, and Zn-phthalocyanine present during the synthesis of these metalla-cages
    通式阳离子芳烃组件的[Ru 6(p -cymene)6(三- PVB)2(μ 2 -Cl)6 ] 6+,的[Ru 6(p -cymene)6(三- PVB)2( OO∩OO)3 ] 6+(tris-pvb = 1,3,5-tris 2-(吡啶-4-基)乙烯基}苯)和[Ru 8(p- Cymene)8(NN∩NN)2(OO∩OO)4 ] 8+(NN∩NN= 1,2,4,5-四2-(吡啶-4-基)乙烯基}苯,1,2,4,5-四2-(吡啶-4-基)乙炔基}苯)是从相应的双核芳烃络合物[Ru 2(p- cymene)2(μ-Cl)2 Cl 2 ]和[Ru 2(p- cymene)2(OO∩OO)Cl 2](OO = OO =草酸,2,5-二氧化-1,4-苯并喹啉酮,2,5-二-1,4-苯并喹啉酮,5,8-二氧化物-1,4-萘醌,5,8-二氧化物-通过与多齿配体三氟甲磺酸反应,生成1
  • Selective cytotoxicity of self-assembled BODIPY metalla-rectangles: Evidence of p53-Dependent apoptosis via both intrinsic and extrinsic pathways
    作者:Gajendra Gupta、Abhishek Das、Sourav Panja、Ji Yeon Ryu、Junseong Lee、Nripendranath Mandal、Chang Yeon Lee
    DOI:10.1016/j.dyepig.2020.108478
    日期:2020.9
    [Ir2(Cp*)2(dhaq)Cl2] (dhaq = 1,4-dihydroxyanthraquinone) and AgCF3SO3 followed by the addition of different substituted BODIPYR ligands (R = CH3, PhCF3, Ph; BODIPY = boron-dipyrromethene) in methanol formed six novel cationic tetranuclear metalla-rectangles [Ru4(p-cymene)4(BODIPYR)2(dhaq)2]4+ (R = CH3, 1; PhCF3, 2; Ph = 3) and [Ir4(Cp*)4(BODIPYR)2(dhaq)2]4+ (R = CH3, 4; PhCF3, 5; Ph = 6). These tetracationic products
    属基配合物的合成中使用荧光配体对于亚细胞定位研究具有若干优点。然而,迄今为止,很少有具有发光特性的属大环化合物被详细研究。为了详细了解其作用机理,设计了一系列带有醌夹的新型Ru(II)和Ir(III)BODIPY基属大环化合物。[Ru 2(p- cymene )2(dhaq)Cl 2 ]或[Ir 2(Cp *)2(dhaq)Cl 2 ](dhaq = 1,4-二羟基蒽醌)和AgCF 3 SO 3之间的反应是随后进行的添加不同的取代BODIPYR配体(R = CH3,PhCF 3,Ph; BODIPY =-二吡咯亚甲基)的甲醇形成六大新型阳离子四环metalla-矩形的[Ru 4(对伞花烃)4(BODIPYR)2(醌)2 ] 4+(R = CH 3,1 ; PhCF 3,2 ;博士=  3)和物[Ir 4(的Cp *)4(BODIPYR)2(醌)2 ] 4+(R = CH 3,4 ;
查看更多